News

Basking Biosciences to Present Clinical Trial Results on First Reversible Thrombolytic Agent at American Heart Association International Stroke Conference 2023

Alleviant Medical Closes $75M in Financing; Receives FDA IDE Approval for Pivotal Clinical Trial

Rocket Pharmaceuticals Provides Update on Anticipated Registration Path for RP-A501 in Danon Disease Following End-of-Phase 1 FDA Meeting

CRANBURY, N.J.--(BUSINESS WIRE)--Dec. 22, 2022-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company...

Comanche Biopharma Announces Appointment of Allison August, M.D., as Chief Medical Officer

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance Artificial Intelligence Platform for Heart Disease

Rocket Pharmaceuticals Completes Acquisition of Renovacor

CRANBURY, N.J.--(BUSINESS WIRE)--Dec. 1, 2022-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company...